Date: Oct 8, 2025
Category: Health & Technology
AstraZeneca has entered into a landmark agreement with Algen Biotechnologies, licensing the innovative AI-powered gene-editing platform, AlgenBrain, in a deal valued at up to $555 million. This strategic partnership grants AstraZeneca exclusive rights to develop and commercialize therapies targeting immune system-related disorders using AlgenBrain’s advanced technology. In exchange, Algen will receive upfront payments as well as milestone-based compensation tied to the development and approval of new therapies. The collaboration underscores AstraZeneca’s commitment to harnessing artificial intelligence and cutting-edge gene-editing tools to accelerate the discovery and delivery of next-generation immune therapies. According to Reuters, this deal positions both companies at the forefront of biotech innovation, with the potential to transform treatment options for patients with immune-related conditions. Read the source »
Share on:
Researchers have made a groundbreaking discovery, demonstrating how bacteria can trigger itch by stimulating nerve cells in the skin. This revelation holds potential for the development of innovative...
SonoBreasts, the sole clinic in Los Angeles with a SonoCine Automated Whole Breast Ultrasound, is dedicated to making breast health more accessible. Jasmine Khorsandi and SonoBreasts are leveraging...
Recent surveys indicate that consumers are optimistic about AI's potential to revolutionize healthcare, despite some reservations. As AI continues to make headlines, its role in transforming...
A groundbreaking AI model, trained on the life data of over a million individuals, has demonstrated the ability to predict an individual's lifespan with remarkable accuracy. This innovative...
A groundbreaking achievement in medical science, the world's first partial heart transplant has successfully grown valves and arteries after over a year of research. Duke Health's pioneering...
As the one-size-fits-all approach to healthcare evolves, the focus shifts to personalized medicine. This shift promises safer and more effective treatments tailored to individual needs, ultimately...